Australia markets closed

Corcept Therapeutics Incorporated (CORT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
18.23-3.71 (-16.91%)
At close: 04:00PM EST
18.00 -0.23 (-1.26%)
After hours: 07:57PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
352,891
353,874
306,486
251,247
159,201
Cost of revenue
5,181
5,582
5,504
5,215
3,554
Gross profit
347,710
348,292
300,982
246,032
155,647
Operating expenses
Research development
113,620
114,764
89,017
75,247
40,376
Selling general and administrative
115,767
105,326
100,359
81,289
62,416
Total operating expenses
229,387
220,090
189,376
156,536
102,792
Operating income or loss
118,323
128,202
111,606
89,496
52,855
Interest expense
-
-
-
-
49
Income before tax
119,077
131,602
116,676
92,153
52,806
Income tax expense
12,624
25,591
22,495
16,743
-76,316
Income from continuing operations
106,453
106,011
94,181
75,410
129,122
Net income
106,453
106,011
94,181
75,410
129,122
Net income available to common shareholders
106,453
106,011
94,181
75,410
129,122
Basic EPS
-
0.92
0.82
0.65
1.14
Diluted EPS
-
0.85
0.77
0.60
1.04
Basic average shares
-
115,412
114,349
115,343
113,527
Diluted average shares
-
124,194
122,566
126,688
124,515
EBITDA
-
130,439
113,777
89,732
52,961